DailyIQ
Last updated3 minutes ago

FMC·FMC Corporation

$10.09
-0.10 (-0.98%)
Overnight$10.20+0.11 (+1.09%)
High
$10.31
Open
$10.08
Market Cap
1.26B
52W High
$36.35
Low
$9.71
P. Close
$10.09
P/E
-
52W Low
$9.70
Fwd P/E
6.22
DailyIQ Est.
$13.48
Inst. Ownership
62.5%
Short Interest
23.86%
Days to Cover
11.5
Technical Score (1D)
23
SELL
News Sentiment
67
BULLISH
FMC’s partnership with AgroSpheres has just moved two RNA‑based bioinsecticide candidates from laboratory validation into global field trials in the United States, Brazil, and Asia, a milestone that signals the company is one step closer to commercial readiness. The transition to real‑world testing means the products will now be evaluated under diverse climatic and agronomic conditions, providing data that could unlock regulatory approvals and market entry. If the field trials confirm the efficacy and safety profiles seen in the lab, FMC could capture a share of the rapidly expanding sustainable crop protection market, which is currently shifting away from conventional chemical insecticides. This potential shift in product mix would strengthen FMC’s competitive positioning and could broaden its revenue base beyond its traditional pesticide offerings. Over the next 1–10 trading days, investors should watch for any press releases or regulatory updates that confirm trial results or grant approvals, as these could materially influence the company’s growth trajectory. Additionally, market reactions to any early performance data from the trials will be a key indicator of investor confidence in FMC’s bioinsecticide pipeline. Finally, keep an eye on any announcements regarding partnerships or supply‑chain arrangements that could accelerate commercialization once the trials prove successful.
Earnings Summary
FMC Corporation operates as a global agricultural sciences company, focusing on crop protection products such as insecticides, herbicides, and fungicides, and serves a broad international customer base across North and Latin America, Europe, the Middle East, Africa, and Asia. The company’s business is embedded in the agricultural inputs sector, where demand is closely tied to crop yields and commodity prices. In the most recent quarter, Q2 2026, FMC reported EPS of $0.26 versus an estimate of $0.2256, a modest beat, while revenue of $841.4 million fell short of the $914.2 million estimate, reflecting a 20% YoY decline and a missed consensus. Compared to Q1 2026, where EPS was $-0.23 versus an estimate of $-0.3354 and revenue was $758.6 million versus an estimate of $751.8 million, the company showed a slight improvement in profitability but continued revenue weakness. Over the last four quarters, FMC has consistently delivered EPS above estimates in three of the four periods, yet revenue growth has been volatile, with Q4 2025 revenue of $1.0833 billion falling below the $1.1625 billion estimate and Q3 2025 revenue of $542.2 million indicating a sharp decline. Historically, the company has maintained YoY revenue growth in the mid‑single digits for several years, but the recent loss of patent protection on its high‑margin insecticide Rynaxypyr has introduced margin compression risks, as noted in the news. The Keybanc coverage lift to an overweight rating and $16 price target signals renewed confidence in FMC’s earnings trajectory, yet analysts caution that the loss of exclusivity and a weak crop price environment could erode profitability. Investors should watch for any subsequent guidance that clarifies revenue outlook and margin expectations, monitor updates on potential licensing or new product launches to offset the Rynaxypyr loss, and keep an eye on commodity price trends and regulatory developments that could materially impact FMC’s earnings in the next quarter.

EPS

EstBeatMiss
$-0.57$-0.06$0.44$0.94$1.45Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$0.11 - -
Q2'26$0.23$0.26+15.2%
Q1'26$-0.34$-0.23+31.4%
Q4'25$1.21$1.20-1.2%
Q3'25$0.85$0.89+4.1%
Q2'25$0.62$0.69+11.2%

Revenue

EstBeatMiss
$449M$651M$852M$1.1B$1.3BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$881M - -
Q2'26$914M$841M-8.0%
Q1'26$752M$759M+0.9%
Q4'25$1.2B$1.1B-6.8%
Q3'25 - $542M -
Q2'25 - $1.1B -

Market Data

FMC Stock Snapshot

SELL23/100
$10.20+$0.11 (1.1%)
Market cap
1.26B
Day range
$9.71 – $10.31
News sentiment
67/100 · Bullish
Analyst target
$13.57 (+33.0%)
Consensus
Hold · 22 analysts
52-week range+5.2% off low · -71.9% from high
$9.70$36.35
Price $10.20 DailyIQ Est. $13.48

FMC's technical picture is under pressure, with momentum working against price. At this size, a single catalyst moves the stock further than it would a larger peer.

Behaviour On Record

What FMC's own history says about today's numbers

Realized volatility (21d)
66.2% 95th pct
Below its peak
-92.8%
vs 200-day average
-25.0%
Up days (1y)
44%

FMC Corporation is currently running 66.2% annualised volatility over the last 21 sessions. Measured against FMC's own 13 years of daily returns rather than a market-wide average, that is the 95th percentile an extreme by its own standards, against a typical reading of 28.2%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

FMC is trading -92.8% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -29.0%, and the deepest was -78.5% in 2025. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.

Price sits -25.0% from its 200-day moving average. Against every other day in its history, that gap ranks at the 14th percentile a narrower gap than it typically runs. Over the past year FMC closed higher on 44% of sessions, and it is currently 3 sessions into a falling streak.

On September specifically: over 13 years of records, FMC finished the month higher 5 of 13 times, with a median return of -3.0% and an average of -5.3%. Its strongest month historically has been November at +4.2% on average, its weakest September at -5.3%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: FMC has opened more than 2% away from the prior close in 175 of 3,266 sessions (5.4% of the time), with the largest gaps running +26.1% and -13.6%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

Across the last 3 dated reports on file, FMC moved an average of 13.7% in the session after earnings, closing higher 1 of those 3 times, with a median move of -2.5% and a largest of -19.4%.

All figures computed from 3,267 daily closes between 2013-09-23 and 2026-09-18, split-adjusted, recomputed daily. Percentiles are against FMC's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of FMC's sector?

FMC Corporation sits in the Materials sector, currently ranked 7th of 11 GICS sectors by relative-strength rotation score (lagging).

Sector rank
#7 of 11
Sector state
Lagging
Sector rotation score
20

Options Market

What is the options market pricing for FMC?

CallsPuts

For FMC Corporation's nearest expiry (2026-10-16, 25 days out), open interest is roughly balanced between puts and calls (put/call ratio of 1.07), with at-the-money implied volatility around 69.1%. The options market is pricing roughly a ±18.4% move by that expiry — a range of about $9.77–$14.17.

Put/call ratio (2026-10-16)
1.07
ATM implied volatility
69.1%
Total open interest
5,932
Expected move by 2026-10-16
±18.4% ($9.77–$14.17)

Analyst Rating Changes

Are analysts turning bullish or bearish on FMC?

Keybanc most recently initiated coverage on FMC Corporation to Overweight on Sep 11, 2026 with a price target of $16. Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action
KeybancOverweight
90-day upgrades
0
90-day downgrades
0
Net rating momentum
0
DateFirmActionRatingPrice target
Sep 11, 2026KeybancInitiatedOverweight$16
Aug 3, 2026RBC CapitalMaintainedSector Perform$12 → $11
Jul 31, 2026CitigroupMaintainedNeutral$14 → $12
Jul 31, 2026JP MorganMaintainedNeutral$16 → $12
Jul 31, 2026Morgan StanleyMaintainedEqual-Weight$16 → $12
Jul 27, 2026BarclaysMaintainedUnderweight$13 → $11
Jul 21, 2026RBC CapitalMaintainedSector Perform$14 → $12
Jun 22, 2026CitigroupMaintainedNeutral$17 → $14
May 1, 2026CitigroupMaintainedNeutral$15 → $17
May 1, 2026RBC CapitalMaintainedSector Perform$16 → $17
May 1, 2026JP MorganMaintainedNeutral$15 → $16
Apr 24, 2026RBC CapitalMaintainedSector Perform$14 → $16

FMC Competitive Positioning

FMC Corporation (FMC) is tracked alongside these names in Agricultural Inputs on DailyIQ — ranked by market cap, with today's move alongside.